Even though CD44 is one of the NF-kB signature genes and a known marker for the discrimination between GCB and ABC DLBCL [153], this is the first report of MyD88L265P directly enhancing the expression and surface levels of CD44. Here, NFKB1 is linked to diffuse large B-cell lymphoma.